Managing Critically Ill Hematology Patients: Time to Think Differently

The number of patients living with hematological malignancies (HMs) has increased steadily over time. This is the result of intensive and effective treatments that also increase the probability of infiltrative, infectious or toxic life threatening event. Over the last two decades, the number of patients with HMs admitted to the ICU increased and their mortality has dropped sharply. ICU patients with HMs require an extensive diagnostic workup and the optimal use of ICU treatments to identify the reason for ICU admission and the nature of the complication that explains organ dysfunctions.

Source: Blood Reviews - April 26, 2015 Category: Hematology Authors: Elie Azoulay, Frédéric Pène, Michael Darmon, Etienne Lengliné, Dominique Benoit, Marcio Soares, Francois Vincent, Fabrice Bruneel, Pierre Perez, Virginie Lemiale, Djamel Mokart, Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique (Grr Tags: Review Source Type: research